In our SCD mouse model, hemopexin in a dose-dependent manner ameliorated vaso-occlusion regardless of whether the vaso-occlusion was triggered by hemoglobin or by a heme-independent trigger, hypoxia-reoxygenation. This evidence concerns the gene HPX and Schnyder corneal dystrophy.